32
Views
6
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

For a rapid diagnosis of acute myocardial infarction, a sensitive troponin assay is needed in the near-patient testing setting

&
Pages 309-312 | Published online: 10 Jan 2014

References

  • Thygesen K, Mair J, Katus H et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur. Heart J.31(18), 2197–2204 (2010).
  • Kavsak PA, Allen LC, Apple FS et al. Cardiac troponin testing in the acute care setting: ordering, reporting, and high sensitivity assays – an update from the Canadian society of clinical chemists (CSCC). Clin. Biochem.44(16), 1273–1277 (2011).
  • MacRae AR, Kavsak PA, Lustig V et al. Assessing the requirement for the 6-hour interval between specimens in the American Heart Association classification of myocardial infarction in epidemiology and clinical research studies. Clin. Chem.52(5), 812–818 (2006).
  • Keller T, Zeller T, Peetz D et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N. Engl. J. Med.361(9), 868–877 (2009).
  • Apple FS, Collinson PO. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin. Chem.58(1), 54–61 (2012).
  • Kavsak PA, MacRae AR, Newman AM et al. Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction. Clin. Chim. Acta380(1–2), 213–216 (2007).
  • Kavsak PA, Hill SA, Bhanich Supapol W, Devereaux PJ, Worster A. Biomarkers for predicting serious cardiac outcomes at 72 hours in patients presenting early after chest pain onset with symptoms of acute coronary syndromes. Clin. Chem.58(1), 298–302 (2012).
  • Goodacre S, Bradburn M, Fitzgerald P et al. The RATPAC (Randomised Assessment of Treatment using Panel Assay of Cardiac markers) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Health Technol. Assess.15(23), 1–102 (2011).
  • Collinson P, Goodacre S, Gaze D et al. Very early diagnosis of chest pain by point-of-care testing: comparison of the diagnostic efficiency of a panel of cardiac biomarkers compared with troponin measurement alone in the RATPAC trial. Heart98(4), 312–318 (2012).
  • Eggers KM, Oldgren J, Nordenskjöld A, Lindahl B. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am. Heart J.148(4), 574–581 (2004).
  • Eggers KM, Jaffe AS, Venge P, Lindahl B. Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain – an evaluation with respect to the universal definition of myocardial infarction. Clin. Chim. Acta412(1–2), 91–97 (2011).
  • Apple FS, Pearce LA, Smith SW, Kaczmarek JM, Murakami MM. Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events. Clin. Chem.55(5), 930–937 (2009).
  • Kavsak PA, Ko DT, Wang X, Macrae AR, Jaffe AS. 2007 universal myocardial infarction definition change criteria for risk stratification by use of a high-sensitivity cardiac troponin I assay. Clin. Chem.56(3), 487–489 (2010).
  • Kavsak PA, MacRae AR, Yerna MJ, Jaffe AS. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin. Chem.55(3), 573–577 (2009).
  • Venge P, Johnston N, Lindahl B, James S. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. J. Am. Coll. Cardiol.54(13), 1165–1172 (2009).
  • Reichlin T, Hochholzer W, Bassetti S et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N. Engl. J. Med.361(9), 858–867 (2009).
  • Body R, Carley S, McDowell G et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J. Am. Coll. Cardiol.58(13), 1332–1339 (2011).
  • Kavsak PA, Ko DT, Wang X, MacRae AR, Jaffe AS. Increasing cardiac troponin changes measured by a research high-sensitivity troponin I assay: absolute vs percentage changes and long-term outcomes in a chest pain cohort. Clin. Chem.56(12), 1902–1904 (2010).
  • Mueller M, Biener M, Vafaie M et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin. Chem.58(1), 209–218 (2012).
  • Body R, McDowell G, Carley S, Wibberley C, Ferguson J, Mackway-Jones K. A FABP-ulous ‘rule out’ strategy? Heart fatty acid binding protein and troponin for rapid exclusion of acute myocardial infarction. Resuscitation82(8), 1041–1046 (2011).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.